The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate.
Kimia KohestaniMarianne MånssonRebecka Arnsrud GodtmanJohan StranneJonas WallströmSigrid V CarlssonMikael HellströmJonas HugossonPublished in: Scandinavian journal of urology (2021)
The Göteborg-2 trial will provide new knowledge about the performance of prostate MRI in a screening setting.